Cargando…
Nigella Sativa Supplementation Accelerates Recovery from Mild COVID-19: First Randomized Controlled Trial
Autores principales: | Koshak, Abdulrahman, Koshak, Emad A, Mobeireek, Abdullah F, Badawi, Mazen A, Wali, Siraj O, Malibary, Husam M, Atwah, Ali F, Alhamdan, Meshari M, Almalki, Reem A, Madani, Tariq A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier GmbH
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696021/ http://dx.doi.org/10.1016/j.eujim.2021.101899 |
Ejemplares similares
-
Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial
por: Koshak, Abdulrahman E., et al.
Publicado: (2020) -
Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial
por: Koshak, Abdulrahman E., et al.
Publicado: (2021) -
Medicinal benefits of Nigella sativa in bronchial asthma: A literature review
por: Koshak, Abdulrahman, et al.
Publicado: (2017) -
Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies
por: Koshak, Dr Abdulrahman E., et al.
Publicado: (2020) -
Comparative Immunomodulatory Activity of Nigella sativa L. Preparations on Proinflammatory Mediators: A Focus on Asthma
por: Koshak, Abdulrahman E., et al.
Publicado: (2018)